Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ann Wiegand

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|October 26, 2013
Single-copy quantification of HIV-1 in clinical samplesAnn Wiegand, Frank Maldarelli
Journal of Visualized Experiments : Jove|October 5, 2011
Amplifying and quantifying HIV-1 RNA in HIV infected individuals with viral loads below the limit of detection by standard clinical assaysHelene Mens, Mary Kearney, Ann Wiegand, et al.
Mbio|January 13, 2021
Mechanistic Analysis of the Broad Antiretroviral Resistance Conferred by HIV-1 Envelope Glycoprotein MutationsYuta Hikichi, Rachel Van Duyne, Phuong Pham, et al.
Plos One|February 27, 2010
Antiretroviral intensification and valproic acid lack sustained effect on residual HIV-1 viremia or resting CD4+ cell infectionNancie M Archin, Manzoor Cheema, Daniel Parker, et al.
Open Forum Infectious Diseases|October 13, 2018
Ongoing HIV Replication During ART ReconsideredMary F Kearney, Ann Wiegand, Wei Shao, et al.
Journal of Virology|November 20, 2015
Origin of Rebound Plasma HIV Includes Cells with Identical Proviruses That Are Transcriptionally Active before Stopping of Antiretroviral TherapyMary F Kearney, Ann Wiegand, Wei Shao, et al.
Journal of Virology|March 4, 2011
Clonal sequences recovered from plasma from patients with residual HIV-1 viremia and on intensified antiretroviral therapy are identical to replicating viral RNAs recovered from circulating resting CD4+ T cellsJeffrey A Anderson, Nancie M Archin, William Ince, et al.
Journal of Virology|October 8, 2010
HIV-1 continues to replicate and evolve in patients with natural control of HIV infectionHelene Mens, Mary Kearney, Ann Wiegand, et al.
Plos One|January 26, 2018
Lower pre-ART intra-participant HIV-1 pol diversity may not be associated with virologic failure in adultsMary F Kearney, Jonathan Spindler, Ann Wiegand, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 12, 2008
Low-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapySarah Palmer, Frank Maldarelli, Ann Wiegand, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Methods in Molecular Biology (Clifton, N.J.)|October 26, 2013
Single-copy quantification of HIV-1 in clinical samplesAnn Wiegand, Frank Maldarelli
Journal of Visualized Experiments : Jove|October 5, 2011
Amplifying and quantifying HIV-1 RNA in HIV infected individuals with viral loads below the limit of detection by standard clinical assaysHelene Mens, Mary Kearney, Ann Wiegand, et al.
Mbio|January 13, 2021
Mechanistic Analysis of the Broad Antiretroviral Resistance Conferred by HIV-1 Envelope Glycoprotein MutationsYuta Hikichi, Rachel Van Duyne, Phuong Pham, et al.
Plos One|February 27, 2010
Antiretroviral intensification and valproic acid lack sustained effect on residual HIV-1 viremia or resting CD4+ cell infectionNancie M Archin, Manzoor Cheema, Daniel Parker, et al.
Open Forum Infectious Diseases|October 13, 2018
Ongoing HIV Replication During ART ReconsideredMary F Kearney, Ann Wiegand, Wei Shao, et al.
Journal of Virology|November 20, 2015
Origin of Rebound Plasma HIV Includes Cells with Identical Proviruses That Are Transcriptionally Active before Stopping of Antiretroviral TherapyMary F Kearney, Ann Wiegand, Wei Shao, et al.
Journal of Virology|March 4, 2011
Clonal sequences recovered from plasma from patients with residual HIV-1 viremia and on intensified antiretroviral therapy are identical to replicating viral RNAs recovered from circulating resting CD4+ T cellsJeffrey A Anderson, Nancie M Archin, William Ince, et al.
Journal of Virology|October 8, 2010
HIV-1 continues to replicate and evolve in patients with natural control of HIV infectionHelene Mens, Mary Kearney, Ann Wiegand, et al.
Plos One|January 26, 2018
Lower pre-ART intra-participant HIV-1 pol diversity may not be associated with virologic failure in adultsMary F Kearney, Jonathan Spindler, Ann Wiegand, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 12, 2008
Low-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapySarah Palmer, Frank Maldarelli, Ann Wiegand, et al.
Pageof 4